NoLimit Foundation

NoLimit is a generative artificial intelligence biotechnology company that integrates advanced AI models with decentralized science (DeSci) to accelerate the discovery and development of novel therapeutics. The company utilizes a proprietary generative AI platform to identify high-potential biological targets and design optimized drug candidates, including both small molecules and biologics. Founded by pioneers in the AI-biotech industry, NoLimit focuses on addressing complex diseases in oncology, immunology, and longevity. By leveraging a decentralized ecosystem through the NoLimit Foundation, the company aims to democratize access to biological data and foster global collaboration in drug R&D. NoLimit's approach is designed to significantly reduce the time and cost associated with traditional drug discovery cycles. The company is headquartered in Abu Dhabi and operates at the intersection of generative biology, chemistry, and blockchain technology.